Has Albert Contento received payments from drug or device companies?

Yes. Drug and device makers reported $9,532 in general payments to Albert Contento across 334 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Albert Contento did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Albert Contento come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Albert Contento

Optometrist · Bronx, NYNPI 1659473155

Payments from drug & device makers

$9,532in general payments, 2019–2025

Across 334 payments — averaging $28.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Bausch & Lomb Americas Inc.$1K
Johnson & Johnson Vision Care, Inc.$1K
Novartis$1K
Biotissue Holdings Inc.$657
Bausch & Lomb, A Division Of Bausch Health US, LLC$508
plus $3K from 15 others

What the payments were for

Consulting fees$1,23513%
Food & beverage$8,29787%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	104	$2,198
Bausch & Lomb Americas Inc.	47	$1,268
Johnson & Johnson Vision Care, Inc.	2	$1,259
Novartis	49	$1,037
Biotissue Holdings Inc.	23	$657
Bausch & Lomb, A Division Of Bausch Health US, LLC	20	$508
Amgen(2 entities)	14	$396
Coopervision Inc.	9	$371
Alcon	11	$334
Lumenis BE Inc	1	$310
Oyster Point Pharma, Inc.	18	$295
Sun Pharmaceutical Industries Inc.	10	$260
Sight Sciences, Inc.	2	$171
Shire North American Group Inc	9	$160
Harrow Eye, LLC	4	$84
Eyevance Pharmaceuticals LLC	4	$83
Aerie Pharmaceuticals, Inc.	2	$48
Tarsus Pharmaceuticals, Inc.	2	$47
Kala Pharmaceuticals, Inc.	1	$17
Ocular Therapeutix, Inc.	1	$16
Heidelberg Engineering, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,532 in reported general payments places this provider in the 95th percentile of 2,743 optometrist providers in New York.

See all optometrist providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XiidraLifitegrast	126	$170,729
MieboPerfluorohexyloctane/Pf	69	$54,703
RestasisCyclosporine	47	$38,952
LumiganBimatoprost	51	$29,354
TyrvayaVarenicline Tartrate	29	$18,120
RocklatanNetarsudil Mesylat/Latanoprost	17	$6,805
VyzultaLatanoprostene Bunod	16	$6,512
Brimonidine Tartrate	41	$6,082
SimbrinzaBrinzolamide/Brimonidine Tart	11	$2,888
Timolol Maleate	32	$1,960
Tobramycin-DexamethasoneTobramycin/Dexamethasone	64	$1,619
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	99	$1,541
Prednisolone Acetate	33	$1,096
Latanoprost	110	$864
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	54	$429

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Bausch & Lomb Americas Inc.Xiidra, Miebo, Vyzulta	$1,268	$231,944211 claims
AbbVieRestasis, Lumigan	$2,198	$68,30698 claims
Oyster Point Pharma, Inc.Tyrvaya	$295	$18,12029 claims
Aerie Pharmaceuticals, Inc.Rocklatan	$48	$6,80517 claims
AlconSimbrinza	$334	$2,88811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,743 optometrist providers in New York.

Other optometrist in Bronx

Evan KaplanBronx$19K
Eleonora OrloffBronx$16K
David GarciaBronx$10K
Katari CampbellBronx$10K
Elizabeth YusupovBronx$10K
Andrew SaccoVestal$1.8M
George ZikosNew York$1M
Roy KlineLake Katrine$822K
Irene FrantzisNew York$663K
Daphne AmbroseNew York$509K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →